mylife Stories

Around 75 employees develop, produce and distribute our pen needles, which are manufactured in Solothurn and delivered from Burgdorf all over the world. It all started small: When the first needles were produced in Burgdorf 30 years ago, the team was still relatively small and production and assembly were still together. In 2009, production was moved to Solothurn and capacity was increased. Since then, the pen needles have developed into a success story that keeps Ypsomed in line with current trends and offers products that are, in some cases, unique in the world.

mylife Stories

With the mylife YpsoPump, we created a small and lightweight insulin pump which is easy and intuitive to use. But this was just the beginning of our journey with the goal to improve life for people with diabetes.

Emmie’s experience with adaptive automated insulin delivery

mylife Stories

After trying various therapy options, Emmie met with our mylife team to discuss a possible switch to mylife Loop: as one of the only licensed loop systems available for children. In just a couple of weeks Emmie and her family have already started to see a positive change to their lives.

Ypsomed has entered into a cooperation with CamDiab Ltd. to further simplify your diabetes therapy. CamDiab Ltd. is the developer of CamAPS FX, an easy to set up and use app which works seamlessly with your Dexcom G6 sensor and your mylife YpsoPump insulin pump. Thanks to the upcoming integration of automated insulin delivery into the mylife YpsoPump system, you will be afforded more time away from your diabetes, and more spontaneity in your daily life. This easy-to-use loop solution will be launched for the mylife YpsoPump system, starting in selected countries and followed by other Ypsomed territories in the course of the year.